Our results showed that the markers of cardiac hypertrophy were upregulated in the Ang II-treated group, but their expression was significantly downregulated in a concentration-dependent manner following LMK235 treatment (Fig. 3L-O). The gene discussed is AGT; the disease is cardiac hypertrophy.